Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by longondmxon Dec 31, 2015 1:12pm

81 Views

Post# 24422353

RE:RE:RE:Wow... Microbix Announces Delay in Filing of Annual Financia

At least they had the foresight to include a statement to the effect that nothingmaterial has caused the delay in filing that has not been disclosed before. Nonetheless, this is not acceptable. How complex is their company that would result in a delay. Did they not engage their auditors in time? more info would be helpful.

Bullboard Posts

The investment impact of the U.S. 25% tariff on Canadian imports